The FDA recently labeled a recall of Abbott (NYSE: ABT) + Abbott Laboratories $105.79 1.58% Open 107.32 Day High 107.32 52 ...

announced Monday that two heart pump products are being recalled after reports of 14 deaths and hundreds of injuries were associated with the devices. Abbott Laboratories’ Thoratec Corp. is ...

Abbott is recalling a system monitor used with the Heartmate cardiac pump because screen display issues could pose a risk to patients. The Class 1 recall affects 4,842 ...

Abbott also recently recalled a Heartmate communication system. The Heartmate pump is used to support blood circulation in patients with severe left ventricular heart failure. The system takes ...

In an emailed response, Abbott said it had communicated ... adverse events," he said. The recall involves a pair of mechanical pumps that help the heart pump blood when it can't do so on its ...

Most recently, Abbott recalled the HeartMate 3 implant kit after complaint ... The video below, courtesy of Abbott, shows how the HeartMate 3 works, how mechanical heart pumps have evolved over time ...

FDA reports 81 incidents, 70 injuries, and 2 deaths related to Abbott heart pump's blood leakage or air entry. Learn about the company's corrective measures.

The FDA has issued a recall for Abbott's HeartMate 3 artificial heart devices, critical for heart transplant patients, due to ...

Federal health officials said that nearly 14,000 heart devices tied ... are being voluntarily recalled. The Department of Justice announced an investigation into Abbott Laboratories' Michigan ...

It has been classified by the US Food and Drug Administration as a Class I recall, the most serious type. The newer-generation HeartMate 3 is used for support in adults and children with severe left ...

An Abbott device that failed heart disease patients is getting a new life in patients with severe vascular disease. The device is a below-knee stent that widens clogged blood vessels, and then ...